Main Logo
Menu
About Us
Our Philosophy
The Industry and Us
Our Strategy
Our Technology
Key Applications
Clinical Programs
Preclinical Programs
Pipeline
Our Partnerships
Our Team
Executive Management
Board of Directors
Clinical Advisory Board
Media / Science Center
Contact Us
Investors
Events & Presentations
Investors
Investors
Overview
News
Press Releases
Email Alerts
In The News
Videos
Events & Presentations
Events
Presentations
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
Filings & Financials
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Management Team
Investor Resources
Contacts
Email Alerts
FAQs
Investor Fact Sheet
Recent News
View All News
Jan 8, 2025 8:00am EST
Ensysce Biosciences Issues Annual Shareholder Letter
Dec 23, 2024 8:00am EST
Ensysce Biosciences Regains Full Compliance with Nasdaq
Latest Presentation
View All Presentations
Dec 13, 2024
Ensysce Corporate Overview
View All Presentations
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings
Sign Up
Email Alerts
Company Profile
Contacts
RSS News Feed